Anhui Anke Biotechnology Hits Day High with Strong 3.52% Intraday Surge

Anhui Anke Biotechnology (Group) Co., Ltd. has experienced a notable increase of 3.52% on June 23, 2026, reaching an intraday high of CNY 8.06. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.37% on the same day. In terms of recent performance, Anhui Anke has shown a weekly gain of 2.32%, while its monthly performance reflects a decrease of 3.05%. Over the past year, the stock has faced challenges, with a decline of 3.87%, significantly underperforming the China Shanghai Composite, which has risen by 21.43% during the same period. The company operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 9,218 million. Key financial metrics include a price-to-earnings ratio of 13.00 and a return on equity of 14.76%. The stock also offers a dividend yield of 3.14%, indicating a commitment to returning value to shareholders. Despite recent gains, the stock's long-term performance remains a point of concern, with a significant decline over the past five and ten years.